文献速递心脏核医学

SPECT心肌灌注显像与心肌灌注熵定量无创评估2型糖尿病大鼠模型冠状动脉微血管功能障碍

Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-08-21

本研究在2型糖尿病大鼠模型中,确定201Tl SPECT心肌灌注显像定量心肌灌注熵(MPE)的最佳条件,并评估利拉鲁肽对冠状动脉微血管功能障碍(CMVD)的影响。可行性研究(n=43)确定多巴酚丁胺负荷及急性NO合酶和环氧合酶抑制为MPE定量最佳条件,T2D动物MPE显著升高(P<0.01 vs 对照)。治疗研究(n=39)显示T2D大鼠MPE显著升高(7.6±0.5 vs 7.1±0.5,P<0.05),利拉鲁肽未显著改善MPE或毛细血管密度。

要点

  • 多巴酚丁胺负荷联合NO合酶和环氧合酶抑制是临床前MPE定量的最佳条件。
  • T2D大鼠MPE显著升高,提示MPE可无创评估CMVD。
  • 利拉鲁肽未显著改善T2D诱导的CMVD(MPE和毛细血管密度均无显著变化)。

核心结论

  • MPE定量可实现临床前无创评估CMVD,MPE和毛细血管密度定量均提示利拉鲁肽未改善T2D诱导的CMVD,MPE用于CMVD评估需进一步临床研究。

研究设计与样本

  • 可行性研究纳入43只高脂饮食联合链脲佐菌素诱导的T2D样大鼠,确定201Tl SPECT MPI定量MPE的最佳条件。
  • 治疗研究纳入39只大鼠,采用超声心动图和死后左心室毛细血管密度评估利拉鲁肽效果及MPE评估CMVD的能力。

主要发现

  • 可行性研究显示T2D动物MPE显著升高(P<0.01 vs 对照)。
  • 治疗研究中T2D大鼠高血糖(5.5±0.5 vs 1.1±0.3 g/L,P<0.001),LVEF显著降低(65±4% vs 74±9%,P<0.01),LV毛细血管密度显著降低(2400±300 vs 2800±600 mm-3,P<0.05)。
  • 利拉鲁肽部分恢复血糖(3.9±0.6 g/L,P<0.05 vs 对照和T2D),完全预防LVEF损害(72±7%,P=NS vs 对照),对毛细血管密度无显著影响。
  • T2D大鼠MPE显著升高(7.6±0.5 vs 7.1±0.5,P<0.05),T2D-LIR大鼠MPE无显著改善(7.4±0.4,P=NS vs 对照和T2D)。

关键数值与推荐

  • MPE定量最佳条件为多巴酚丁胺负荷联合急性NO合酶和环氧合酶抑制。
  • T2D大鼠MPE显著高于对照(P<0.01)。
  • 治疗研究中T2D大鼠MPE显著高于对照(7.6±0.5 vs 7.1±0.5,P<0.05)。

临床怎么用

  • MPE定量可作为临床前无创评估CMVD的工具,但利拉鲁肽未显示改善CMVD,需进一步临床研究验证MPE的临床相关性。

局限性

  • 本研究为临床前动物模型,MPE对CMVD评估的临床相关性需进一步临床研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Coronary microvascular dysfunction (CMVD) plays a major role in the occurrence of cardiovascular events (CVE). We recently suggested the clinical potential of myocardial perfusion entropy (MPE) quantification from SPECT myocardial perfusion images (MPI) for the prognosis of CVE occurrence. We hypothesized that the quantification of MPE from SPECT MPI would allow the assessment of CMVD-related MPE variations in a preclinical model of type 2 diabetes (T2D) including treatment with the anti-diabetic incretin liraglutide (LIR). METHODS: Optimal conditions for the preclinical quantification of MPE using 201Tl SPECT MPI were determined in rats with a T2D-like condition induced by a high-fat diet and streptozotocin injection (feasibility study, n = 43). Using such conditions, echocardiography and post-mortem LV capillary density evaluation were then used in order to assess the effect of LIR and the ability of MPE to assess CMVD (therapeutic study, n = 39). RESULTS: The feasibility study identified dobutamine stress and acute NO synthase and cyclooxygenase inhibition as optimal conditions for the quantification of MPE, with significant increases in MPE being observed in T2D animals (P < 0.01 vs controls). In the therapeutic study, T2D rats were hyperglycemic (5.5 ± 0.5 vs 1.1 ± 0.3 g/L for controls, P < 0.001) and had a significantly lower left ventricular ejection fraction (LVEF) (65 ± 4% vs 74 ± 9%, P < 0.01) and LV capillary density (2400 ± 300 vs 2800 ± 600 mm-3, P < 0.05). LIR partially restored glycemia (3.9 ± 0.6 g/L, P < 0.05 vs controls and T2D), totally prevented LVEF impairment (72 ± 7%, P = NS vs CTL), with no significant effect on capillary density. MPE was significantly increased in T2D rats (7.6 ± 0.5 vs 7.1 ± 0.5, P < 0.05), with no significant improvement in T2D-LIR rats (7.4 ± 0.4, P = NS vs controls and T2D). CONCLUSION: MPE quantification allowed the preclinical noninvasive assessment of CMVD. Both MPE and capillary density quantification suggested that LIR did not improve T2D-induced CMVD. The relevance of MPE for CMVD assessment warrants further clinical investigation.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Carabelli A, Canu M, de Fondaumière M, et al. Noninvasive assessment of coronary microvascular dysfunction using SPECT myocardial perfusion imaging and myocardial perfusion entropy quantification in a rodent model of type 2 diabetes. Eur J Nucl Med Mol Imaging. 2021. PMID: 34417856. doi:10.1007/s00259-021-05511-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。